Clinical Trial Update: A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic Dermatitis [Phase 3]

View source ↗

Summary

A Phase III study evaluating the efficacy and safety of AK120 in adults with moderate to severe atopic dermatitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• AK120

Snippet

Sponsor: Akeso | Conditions: Atopic Dermatitis | Phase 3 | Status: RECRUITING